Trial Outcomes & Findings for Yes/No Questionnaire for Aphasic Patients (YNQ) (NCT NCT03257696)
NCT ID: NCT03257696
Last Updated: 2022-06-10
Results Overview
The Yes/No questionnaire consists in 10 closed-ended questions designed to assess the patient's ability to provide a coherent answer. It was designed with questions that are very easy to answer, with the following constraints: * The questionnaire use only the auditory/verbal channel . * The questions ask only about personal data because they are less ambiguous. * The syntactical construction of the questions is very simple. * Apart from the use of personal data very familiar to the participants, the other nouns in the closed questions are very frequent (according to a lexical database). * The length of the questions was limited to seven words. * With the exception of two questions, each yes-response question had a no-response equivalent, as in some existing tests. A score of zero indicates a wrong answer to all questions. A score of ten indicates a correct answer to all questions.
COMPLETED
152 participants
measured within 7 in-hospital days
2022-06-10
Participant Flow
Participant milestones
| Measure |
Reliable
Patients who respond reliably to closed questions, according to the speech therapist classification
|
Unreliable
Patients who do not respond reliably to closed questions, according to the speech therapist classification
|
|---|---|---|
|
Overall Study
STARTED
|
123
|
29
|
|
Overall Study
COMPLETED
|
123
|
29
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Reliable
n=123 Participants
Patients who respond reliably to closed questions, according to the speech therapist classification
|
Unreliable
n=29 Participants
Patients who do not respond reliably to closed questions, according to the speech therapist classification
|
Total
n=152 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=123 Participants
|
0 Participants
n=29 Participants
|
0 Participants
n=152 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
25 Participants
n=123 Participants
|
7 Participants
n=29 Participants
|
32 Participants
n=152 Participants
|
|
Age, Categorical
>=65 years
|
98 Participants
n=123 Participants
|
22 Participants
n=29 Participants
|
120 Participants
n=152 Participants
|
|
Age, Continuous
|
72.3 years
STANDARD_DEVIATION 12.8 • n=123 Participants
|
75.4 years
STANDARD_DEVIATION 14.7 • n=29 Participants
|
72.8 years
STANDARD_DEVIATION 13.2 • n=152 Participants
|
|
Sex: Female, Male
Female
|
57 Participants
n=123 Participants
|
17 Participants
n=29 Participants
|
74 Participants
n=152 Participants
|
|
Sex: Female, Male
Male
|
66 Participants
n=123 Participants
|
12 Participants
n=29 Participants
|
78 Participants
n=152 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
France
|
123 participants
n=123 Participants
|
29 participants
n=29 Participants
|
152 participants
n=152 Participants
|
|
Diagnostic
Ischemic stroke
|
109 Participants
n=123 Participants
|
24 Participants
n=29 Participants
|
133 Participants
n=152 Participants
|
|
Diagnostic
Hemorrhagic stroke
|
11 Participants
n=123 Participants
|
4 Participants
n=29 Participants
|
15 Participants
n=152 Participants
|
|
Diagnostic
Combination of both stroke subtypes
|
3 Participants
n=123 Participants
|
1 Participants
n=29 Participants
|
4 Participants
n=152 Participants
|
|
Thrombolysis
Thrombolysis
|
29 Participants
n=123 Participants
|
6 Participants
n=29 Participants
|
35 Participants
n=152 Participants
|
|
Thrombolysis
No thrombolysis
|
94 Participants
n=123 Participants
|
23 Participants
n=29 Participants
|
117 Participants
n=152 Participants
|
PRIMARY outcome
Timeframe: measured within 7 in-hospital daysThe Yes/No questionnaire consists in 10 closed-ended questions designed to assess the patient's ability to provide a coherent answer. It was designed with questions that are very easy to answer, with the following constraints: * The questionnaire use only the auditory/verbal channel . * The questions ask only about personal data because they are less ambiguous. * The syntactical construction of the questions is very simple. * Apart from the use of personal data very familiar to the participants, the other nouns in the closed questions are very frequent (according to a lexical database). * The length of the questions was limited to seven words. * With the exception of two questions, each yes-response question had a no-response equivalent, as in some existing tests. A score of zero indicates a wrong answer to all questions. A score of ten indicates a correct answer to all questions.
Outcome measures
| Measure |
Reliable
n=123 Participants
Patients who respond reliably to closed questions, according to the speech therapist classification
|
Unreliable
n=29 Participants
Patients who do not respond reliably to closed questions, according to the speech therapist classification
|
|---|---|---|
|
YNQ Score
YNQ score = 0
|
0 Participants
|
1 Participants
|
|
YNQ Score
YNQ score = 1
|
0 Participants
|
1 Participants
|
|
YNQ Score
YNQ score = 2
|
0 Participants
|
0 Participants
|
|
YNQ Score
YNQ score = 3
|
0 Participants
|
2 Participants
|
|
YNQ Score
YNQ score = 4
|
1 Participants
|
1 Participants
|
|
YNQ Score
YNQ score = 5
|
0 Participants
|
4 Participants
|
|
YNQ Score
YNQ score = 6
|
0 Participants
|
4 Participants
|
|
YNQ Score
YNQ score = 7
|
1 Participants
|
5 Participants
|
|
YNQ Score
YNQ score = 8
|
0 Participants
|
4 Participants
|
|
YNQ Score
YNQ score = 9
|
0 Participants
|
2 Participants
|
|
YNQ Score
YNQ score = 10
|
121 Participants
|
5 Participants
|
Adverse Events
Reliable
Unreliable
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Camille Bonnin
Groupe Hospitalier de la Rochelle Ré Aunis
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place